| Bioactivity | Zimistobart (BMS-986315) is a fully human IgG1 antibody that targets NKG2A. Zimistobart can be used for the study of non-small cell lung cancer (NSCLC). The isotype control for Zimistobart can refer to Human IgG1 kappa, Isotype Control (HY-P99001)[1]. |
| CAS | 2829290-06-2 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Fisher JG, et al. Strategies to disrupt NKG2A:HLA-E interactions for improved anti-cancer immunity. Oncotarget. 2024 Jul 17;15:501-503. |